Deals + Cases

Advestra advises Lonza on the divestment of its Capsules & Health Ingredients (CHI) business

Advestra advises SANDOW on the acquisition of ARCHITONIC

Advestra advises the financing sources on Advent’s acquisition of u-blox

Advestra advises the shareholders of Viterra Limited in the merger with Bunge Global

Advestra advises LOGEX on the acquisition of INMED

Advestra advises the sellers on the sale of IntiQuan AG to ProductLife Group

Advestra advises ENR Russia Invest SA on the public tender offer of its majority shareholder Valartis

Advestra advises eMolecules Inc. and Avista Healthcare Partners on the acquisition of Synple Chem AG

Advestra advises Cactus Life Sciences on the acquisition of nspm and eluSCIdate

Advestra advises funds affiliated with Perceptive Advisors on the launch of Neurosterix

Advestra advises the shareholders of RMB Group on the strategic partnership with eevolve

Advestra advises Marc O'Polo on the acquisition of the Swiss business from distribution partner Bollag-Guggenheim

Advestra advises Catalyst Pharmaceuticals on license to vamorolone and equity investment in Santhera Pharmaceuticals

Advestra advises Ironwood on the cash tender offer for VectivBio